SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (273)6/9/2004 12:53:00 PM
From: tom pope  Read Replies (1) | Respond to of 362
 
You may have bought them from me - I sold a few at 3.79



To: Biomaven who wrote (273)6/9/2004 1:03:24 PM
From: Icebrg  Read Replies (1) | Respond to of 362
 
Peter

I am negatively impressed by the fact that the drug was taken by Vanda. Nothing wrong with them, I suppose, but the fact that Novartis did not want the drug any more and did not manage to find a more traditional special pharma willing to take over the license is not so encouraging.

It would be interesting to have Harry's take on this. I am sure he is lurking somewhere in the background even if he is busy at BIO for the time being.

Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News